NASDAQ:XERS

Xeris Pharmaceuticals Stock Predictions

etoro logo Buy XERS
*Your capital is at risk
$5.89
-0.110 (-1.83%)
At Close: Jun 03, 2026
Currently predicting for Thu, 4 Jun 2026

XERS Prediction Chart

XERS Predictions History

Latest community submissions for XERS.
Predictor Target Session Target Price Result Direction Accuracy Score
Mar 20, 2026 $5.45 -2.25% $5.44 V 99.74% 5
Mar 20, 2026 $5.50 -1.41% $5.44 V 98.87% 2
Mar 20, 2026 $10.00 +84.16% $5.44 V 16.18% 0
Jan 20, 2026 $7.68 +2.07% $7.61 V 99.14% 3
Jan 20, 2026 $7.62 +1.29% $7.61 V 99.90% 10
Jan 20, 2026 $9.12 +23.08% $7.61 V 80.16% 1
Jan 15, 2026 $7.75 +2.19% $7.41 X 95.47% 0
Jan 15, 2026 $7.48 -1.37% $7.41 V 99.10% 3
Jan 15, 2026 Bullish $7.41 X 0
Jan 9, 2026 $7.95 -2.19% $7.93 V 99.72% 5
Click to get the best stock tips daily for free!
Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for XERS with a full price path, not just a one-day call.
  • Price path
  • Approved predictor
  • 3-month horizon
ABOUT XERIS PHARMACEUTICALS INC
Xeris Pharmaceuticals
Xeris Biopharma Holdings, Inc., a biopharmaceutical company, engages in developing and commercializing therapies for patient populations in endocrinology, neurology, and gastroenterology. The company markets Gvoke, a ready-to-use liquid glucagon for the treatment of severe hypoglycemia; and Keveyis, a therapy for the treatment of hyperkalemic, hypokalemic, and related variants of primary periodic paralysis; and Recorlev, a cortisol synthesis inhi...
GOLDEN STAR
Ticker Change Signal Date
LITE
$905.00
3.65% Jun 01
RUN
$12.83
15.74% May 06
GLBE
$31.61
0.569% May 05
SAP
$172.39
4.80% May 05
ADBE
$243.57
5.20% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE